Abstract
The aim of the present study was to investigate the changes in absolute myocardial blood flow (AMF) after intracoronary injections of mesenchymal SC (MSC) and compared to controls in closed-chest reperfused acute myocardial infarction (AMI) in pigs. Male MSCs, transiently transfected with Luciferase (Luc-MSC) were delivered (9.7 ± 1.2 x 10(6)) intracoronary in the open infarct-related artery one-week post-AMI in female pigs (group MSC), while saline was injected with the same injection rate in controls (group C). The AMF was measured immediately after, and 3, 12 and 24 h post-intracoronary Luc-MSC or saline injections. In vitro bioluminescence images and quantitative real-time TaqMan PCR measurements were performed to quantify the sex-mismatched MSCs. No difference between the groups was observed regarding the weight, heart rate, blood pressure and global ejection fraction 1-week post-AMI. The baseline AMF were similar in the groups (61.3 ± 15. vs 61.1 ± 12.0 ml/min). AMF was decreased significantly immediately after intracoronary MSC delivery (42.0 ± 12.4 vs 57.7 ± 15.7 ml/min p = 0.013), and remained low at 3 h (40.9 ± 13.4 vs 55.8 ± 4.9 ml/min, p = 0.004), 12 h (43.0 ± 3.7 vs 57.8 ± 5.4 ml/min, p = 0.001) with incomplete recovery at 24 h (47.2 ± 5.5 vs 62.1 ± 14.1 ml/min, p = 0.038) as compared to controls, respectively. In vitro bioluminescence displayed transfected Luc-MSCs along the proximal and mid part of the LAD, with limited number (295 ± 101 sry copied/million cardiac cells) of Y-chromosome-MSCs in the infarcted area. Intracoronary injection of SCs results in immediate decrease of AMF, with delayed recovery. The delivery of the SC into the injured myocardium might be hindered by the altered coronary pressure and flow conditions.
MeSH Terms
Animals
Cell- and Tissue-Based Therapy/methods
Coronary Circulation/physiology
Female
Hemodynamics
Humans
Male
Mesenchymal Stem Cell Transplantation
Mesenchymal Stem Cells/cytology,physiology
Myocardial Infarction/therapy
Myocardium/cytology
Random Allocation
Regional Blood Flow
Swine
Authors & Affiliations
18 authors, click to expand affiliations / ORCID
Gyöngyösi Mariann
Department of Cardiology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
[email protected]
Hemetsberger Rayyan
Wolbank Susanne
Pichler Valentin
Kaun Christoph
Posa Aniko
Petrasi Zsolt
Petnehazy Örs
Hofer-Warbinek Renate
de Martin Rainer
Gruber Florian
Benedek Imre
Benedek Teodora
Kovacs Istvan
Benedek Istvan
Plass Christian A
Charwat Silvia
Maurer Gerald
References (16)
16 references, click to expand
-
Normalization of coronary blood flow in the infarct-related artery after intracoronary progenitor cell therapy: intracoronary Doppler substudy of the TOPCARE-AMI trial.
Clin Res Cardiol. 2006 Jan;95(1):13-22
PMID: 16598441
-
Direct volumetric blood flow measurement in coronary arteries by thermodilution.
J Am Coll Cardiol. 2007 Dec 11;50(24):2294-304
PMID: 18068038
-
Imaging the migration of therapeutically delivered cardiac stem cells.
JACC Cardiovasc Imaging. 2010 Jul;3(7):772-5
PMID: 20633856
-
Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI).
Circulation. 2002 Dec 10;106(24):3009-17
PMID: 12473544
-
Fate of culture-expanded mesenchymal stem cells in the microvasculature: in vivo observations of cell kinetics.
Circ Res. 2009 Feb 13;104(3):398-402
PMID: 19096027
-
Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) trial.
Circulation. 2007 Jul 24;116(4):366-74
PMID: 17620510
-
Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs.
Lancet. 2004 Mar 6;363(9411):783-4
PMID: 15016490
-
A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction.
Eur Heart J. 2006 May;27(9):1114-22
PMID: 16510464
-
Intracoronary delivery of mesenchymal stem cells at high flow rates after myocardial infarction improves distal coronary blood flow and decreases mortality in pigs.
Catheter Cardiovasc Interv. 2009 Feb 1;73(2):251-7
PMID: 19085935
-
Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.
N Engl J Med. 2006 Sep 21;355(12):1199-209
PMID: 16990383
-
Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.
N Engl J Med. 2006 Sep 21;355(12):1210-21
PMID: 16990384
-
Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue.
J Cell Biochem. 2006 Dec 1;99(5):1285-97
PMID: 16795045
-
Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.
Lancet. 2006 Jan 14;367(9505):113-21
PMID: 16413875
-
Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction.
J Mol Cell Cardiol. 2008 Mar;44(3):486-95
PMID: 18061611
-
Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study.
Nat Clin Pract Cardiovasc Med. 2009 Jan;6(1):70-81
PMID: 19002124
-
Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans.
Circulation. 2002 Oct 8;106(15):1913-8
PMID: 12370212